Close menu




September 1st, 2022 | 12:29 CEST

BYD after Buffett shock - Better to bet on JinkoSolar and Meta Materials?

  • metamaterials
  • Innovations
  • Technology
  • Electromobility
Photo credits: pixabay.com

So, now it is done: Star investor Warren Buffett has sold shares in the Tesla hunter, BYD. Although it is only a small part of the investment, the BYD share went down significantly. Because now, the door is open to speculation about what will happen to the legal shares - Buffett's Berkshire Hathaway still holds almost 19% of the Chinese carmaker. The convincing quarterly figures have thus receded into the background. JinkoSolar has presented mixed figures. The Company is benefiting from the skyrocketing electricity and gas prices. After all, they are driving demand for solar systems, but analysts are divided. Meta Materials' innovative functional materials are also expected to revolutionize renewable energy production in the future. For further development, the patent octopus has now strengthened itself with a veteran of the chip industry.

time to read: 4 minutes | Author: Fabian Lorenz
ISIN: BYD CO. LTD H YC 1 | CNE100000296 , JINKOSOLAR ADR/4 DL-00002 | US47759T1007 , Meta Materials Inc. | US59134N1046

Table of contents:


    BYD: Buffett shock overshadows good figures

    For more than a month, there has been speculation that Warren Buffett's Berkshire Hathaway could divest itself of BYD shares. At the time, a BYD position equal in size to Berkshire's appeared in the Hong Kong stock clearing system under a Citibank account. A stock market report now shows that the stake in BYD fell from 20.49% to 19.92%. The block of shares sold was worth USD 47 million. Not much, but now, there is speculation as to what will happen to the remaining shares. Will more pieces be thrown on the market? Maybe Buffett will part with the entire stake?

    Buffett first took a stake in BYD in 2008. Since then, the share has increased more than twenty-fold. As a result of the report, the BYD share does not benefit from the otherwise good quarterly figures. BYD sold 355,021 vehicles (hybrid and all-electric) in the second quarter, 256% more than in the same period last year. Compared to the first quarter of the current year, the increase is still 24%. Sales increased by 68% YOY to CNY 83.77 billion. BYD is also making progress in terms of profitability. Thus, net profit climbed by 198% to around CNY 2.8 billion in the reporting period. Following the figures, Credit Suisse analysts raised their earnings estimates for the years up to 2024 by up to 40% and the price target to HKD 400. However, this could not slow down yesterday's selling pressure. In trading on the Hong Kong Stock Exchange yesterday, the share lost 12%.

    Meta Materials: Patent octopus brings chip veterans on board

    Operationally, Meta Materials is currently picking up speed. However, the technology company is still at a very early stage, and the focus is on research. Nevertheless, the Canadians, listed in Germany and on the NASDAQ, increased sales in the second quarter by 432% to USD 3.3 million. Meta Materials is working hard to develop high-performance functional materials and nanocomponents. One application example with huge market potential is early detection in the medical field - including strokes. According to the World Stroke Organization, stroke is the second leading cause of death worldwide. Meta Materials is working on a portable and low-cost radio wave imaging scanner. In this effort, Meta Materials aims to provide higher image resolution and faster scans than previous products, all without radiation. Meta's approach has been featured in several technical articles and has already been secured as a US patent. The patent covers a wide range of potential applications, including image detection of breast cancer, brain clots, and the diagnosis of internal bleeding.

    Meta Materials now has a total of 410 active patent documents - of which 251 are issued patents, and 159 are pending patent applications. In the future, high-performance materials with nanotechnology should make it possible to redirect light, sound, heat or radio waves. The potential is gigantic and spans all industries such as 5G communications, health and wellness, aerospace, the automotive industry and renewable energy. As the Company grows, it is also evolving in terms of personnel. For example, Jack Harding, the former executive of chip giant Advanced Micro Devices, was recently appointed Chairman of the Board. Harding is a true veteran of the chip industry. In addition to his time at AMD, he also oversaw the billion-dollar merger of RF Micro Devices and TriQuint Semiconductor to form Qorvo. Should the research and subsequent monetization be successful, a billion-dollar valuation could also be possible for Meta Materials. Currently, the market capitalization of the hot stock is around USD 280 million.

    JinkoSolar: Fair value at USD 71 or USD 35?

    JinkoSolar has already reached a market capitalization of over one billion. When looking at the current figures, however, there could be even more to it than the approximately USD 3.3 billion. This opinion is shared by analysts at BOC International, among others. The experts recommend the share of the Chinese solar cell and solar module producer with "Buy" and a price target of USD 71. In contrast, Goldman Sachs has renewed its sell recommendation. The analysts are skeptical about the coming quarters. Thus, JinkoSolar has problems with cash flow generation and the debt-equity ratio.

    Regarding the numbers: The Chinese company benefited from high demand for its solar modules in the second quarter. Solar modules with an output of 10,183 MW and cells and wafers with 349 MW were delivered. All in all, this was equivalent to around double the previous year's figure. Compared to the same period of the previous year, sales increased by 138% to USD 2.81 billion. However, JinkoSolar's results were disappointing, and the Company even slipped into the red. Thus, the net loss was USD 93 million, compared to a net profit of over USD 9 million in the same quarter last year. In the full year 2022, 35 to 40 GW (modules, cells and wafers) are to be delivered.


    BYD is in a top position operationally, but one should not underestimate the image damage from the Buffett sale. At the hotstock Meta Materials, the new chairman of the board of directors is creating an improved image. JinkoSolar must finally get a grip on profitability, which does not seem to be the case at the moment.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Stefan Bode on September 2nd, 2026 | 07:10 CEST

    Between Renewed Interest Rate Fears, Technological Breakthroughs and Disruptive Competition – Vonovia, dynaCERT and Siemens Energy

    • Hydrogen
    • cleantech
    • RealEstate
    • Energy
    • Technology

    Rising bond yields and restrictive central bank policies are challenging established business models following years of low interest rates. While a real estate giant is grappling with the consequences of tighter monetary policy, a pioneer in clean mobility technology is striving to make the decisive leap from pilot projects to regional market leadership. At the same time, a visionary tech billionaire is causing unrest amongst industry leaders with ambitious expansion plans in the energy sector. Which players can hold their own in this dynamic environment, and where do sensitive share price setbacks loom?

    Read

    Commented by Armin Schulz on September 2nd, 2026 | 07:05 CEST

    Volkswagen, Strategic Resources and TKMS: How to Capitalize on the Mega-Trend of Defence and Raw Materials

    • VTM
    • ironore
    • GreenSteel
    • Defense
    • Electromobility
    • decarbonization

    When a vehicle manufacturer becomes a defence contractor, a raw materials developer provides the key to green steel production, and a naval group reports record orders, a realignment of German industry is taking shape. Volkswagen is on the brink of its most profound transformation and is turning to the defence sector as a lifeline. At the same time, the race for strategic resources is intensifying. Without decarbonized steel, there can be no modern defence, and this steel requires specific grades of iron ore. This is precisely where Strategic Resources comes in. While thyssenkrupp Marine Systems is benefiting from full order books, a new value chain is emerging. Today, we take a closer look at the shares of Volkswagen, Strategic Resources and TKMS.

    Read

    Commented by Fabian Lorenz on September 1st, 2026 | 07:45 CEST

    Potential Moderna-Style Share Surge? Takeover Candidates Evotec, Valneva and Vidac Pharma in Focus — Analysts Bullish

    • Biotechnology
    • Pharma
    • Innovations
    • Oncology

    Moderna has shaken up the biotech market with its breakthrough in the fight against skin cancer. Partner Merck has received somewhat less attention in the coverage, despite preparing for the eventual patent expiration of one of its blockbuster drugs. Other pharmaceutical companies will also need to replenish their pipelines in the coming years. As a result, the takeover merry-go-round is likely to pick up speed again, potentially electrifying investors. One hot candidate is Vidac Pharma. Recruitment for its Phase 2B trial into high-risk actinic keratosis, a precancerous skin condition, has been completed. The results could provide a catalyst for the stock. Valneva's share price has recently risen sharply. Could its partner Pfizer eventually make a move? Analysts are recommending the stock. And what about perennial takeover candidate Evotec? Shareholders and potential buyers are currently giving the share a wide berth. Yet there is a "Buy" recommendation on the table.

    Read